iiinova — where your digital self keeps evolving

Norn Group @norngroup.bsky.social · 12/08/2026

A heart strained by injury or disease can develop fibrosis, where stiff scar tissue builds up and impairs its ability to pump. How does that happen? We funded Michael Alexanian’s lab to work on this. Findings now published in Nature 👇

100

Norn Group @norngroup.bsky.social · 19/07/2026

With age, the immune system can start to look like an overworked security system. It becomes more reactive and sounds more alarms, but gets worse at catching real threats. We funded Korbyn Dahlquist through Norn Group’s Impetus Grants to work on this aging immune bottleneck. 👇

100

Norn Group @norngroup.bsky.social · 12/07/2026

Partial reprogramming could rejuvenate aging cells, but only if we control it precisely. Getting this right depends on our ability to control exactly where, when, and how strongly reprogramming is induced. We funded talent in @harvardmed.bsky.social through Impetus Grants to work on that 👇

100

Norn Group @norngroup.bsky.social · 12/06/2026

Hibernation is linked to unusually long lifespans, but natural torpor bundles lower metabolism, lower body temperature, reduced food intake, and inactivity. Causality has been hard to isolate. We funded Sinisa Hrvatin's lab through Impetus Grants to make progress on that front. 🧵👇

100

Reposted by Norn Group

Barry Bentley, PhD, FRSB @bbentley.bsky.social · 05/06/2026

Over 400 ageing researchers. One unified mission. Today, ICCARP launches its new platform, dedicated to rewriting how ageing-related pathologies are classified, staged & treated worldwide. The reclassification of ageing begins here: iccarp.org #Geroscience #Aging #Ageing #Longevity #ICD11

iccarp.org

ICCARP — International Consortium to Classify Ageing-Related Pathologies

An international consortium of clinicians and scientists developing a systematic classification of ageing-related pathologies, structured for submission to the WHO and ICD-11.

131

Norn Group @norngroup.bsky.social · 06/05/2026

~95% of adults carry Epstein-Barr Virus. It is usually “hidden” and can cause multiple sclerosis and various cancers. But evidence points to a factor that might control whether the virus stays hidden or not: methionine. How? 🧵🪡

100

Reposted by Norn Group

Barry Bentley, PhD, FRSB @bbentley.bsky.social · 27/04/2026

🫁 Now published in @thelancet.com Healthy Longevity: the ICCARP Respiratory Working Group review on how ageing drives respiratory decline & disease, and why this matters for classification & intervention. doi.org/10.1016/j.la... Supported by @norngroup.bsky.social #aging #longevity

021

Norn Group @norngroup.bsky.social · 26/04/2026

Observational analyses are great for identifying patterns to pursue. To get to truth and real progress, we need randomized clinical trial data. To expand the pool of hard-outcomes data in longevity, we funded Matt Kaeberlein's group to run a randomized clinical trial on off-label rapamycin use. 👇

rapamycintrial.com

Rapamycin Trial

FDA approval clinical trial evaluating rapamycin in older adults with periodontal disease

111

Norn Group @norngroup.bsky.social · 23/04/2026

Aging and disease play out at the level of tissues and organs, but many molecular changes are still hard to measure without destroying tissue context in vivo. This often means sacrificing either detail or tissue context in repeated measurements. We funded a talented team to work on solutions 👇

111

Norn Group @norngroup.bsky.social · 16/04/2026

Proteomics gives us a window into the biology of aging, but current studies often miss the full picture because they lack proteome coverage across a complete lifespan. Through Impetus Grants, we are funding Xiao Tian to expand this landscape. 👇

110

Norn Group @norngroup.bsky.social · 15/04/2026

AlphaFold predicted the shape of every known protein, but we are still far from solving the dynamics of protein folding, the process of going from genes to functional macromolecules. If a protein misfolds, cells attempt to fix it, but this is not what always happens 👇

110

Norn Group @norngroup.bsky.social · 07/04/2026

We audit the aging field to map the bottlenecks on the road to aging therapies, & one of the biggest is that most targets still aren’t druggable. More than 2/3s of targets are out of reach for conventional medicines, & gene therapies often trigger an immune response. Why's this problem so hard?👇

110

Norn Group @norngroup.bsky.social · 02/04/2026

Finding actionable drug targets is a primary bottleneck in human longevity research. Through Impetus Grants, we’ve been funding researchers like Ryan Dhindsa @ryandhindsa.bsky.social from the Baylor College of Medicine @bcmhouston.bsky.social to make progress in exactly that 👇

111

Norn Group @norngroup.bsky.social · 31/03/2026

There are more talented scientists working on aging today because of Norn Group. "Impetus grants uniquely find early career scientists right at pivotal moments in their careers and give them the support to take bold steps in aging." - Sophia Liu @sophialiu.bsky.social youtu.be/Ym9cZUuKy98

youtube.com

Impetus Grants Awardee Testimonial - Sophia Liu | Norn Group

YouTube video by Norn Group

100

Norn Group @norngroup.bsky.social · 27/03/2026

A lot of insight in biology is behind experiments that take decades to run, and are therefore rarely started. This paper out this week in Nat Comms describes 20y of cloning a single mouse lineage until the line failed from genomic mutations accumulating with no recombination to filter them out...👇

110

Norn Group @norngroup.bsky.social · 20/03/2026

Congrats @xinjin.bsky.social! The Jin lab at @scripps.edu was previously funded by Impetus Grants to apply their cutting-edge genomic tools to brain rejuvenation (thread 👇)

110

Norn Group @norngroup.bsky.social · 17/03/2026

CAR-T cell therapy reshaped cancer treatment over the past decade. @corina-amor.bsky.social’s lab at CSHL @cshlnews.bsky.social is pointing the same technology at aging, engineering CAR-T cells to recognize and eliminate senescent cells. Impetus was the lab’s first grant 👇

100

Reposted by Norn Group

Satvik Dasariraju @satvik3.bsky.social · 29/11/2024

Concretizing the capabilities of clocks to accelerate discovery in aging biology ⚡ We invite you to join us in building or sponsoring this initiative, and reach out to us for further discussion: team@norn.group

042

Reposted by Norn Group

Martin Borch Jensen @martinbjensen.bsky.social · 29/11/2024

Exciting mix of biotech tools and systems aging biology. Proud to have supported via @norngroup.bsky.social Impetus Grants, and hope for more like it.

072

Norn Group @norngroup.bsky.social · 29/11/2024

@satvik3.bsky.social @martinbjensen.bsky.social propose a path for robustly validating aging clocks to replace lengthy lifespan studies, a 2-10x speedup, by extending the gold-standard lifespan assessment program to generate the data needed to benchmark predictive validity norn.group/agingclocks 🧵

norn.group

133